GLP-1 market in early to middle innings
The guest argued the GLP-1 market is still in the early to middle innings of uptake, with robust growth driven by expanding insurance coverage, new oral versions, and a pipeline of new indications.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.